Establish and Apply the Evaluation System of Ultrasonic Integrated Technology for Prevention and Treatment of Acute Kidney Injury

NCT02347930 | Completed

• 1 other identifier: 2014DFT30090
• Study Type: observational
• Target: 196
• Locations: 1 country
• Sites: 1

Brief Summary

Establish an integrated evaluation system of ultrasound technology for the prognosis of acute kidney injury, and in order to achieve non-invasive, reliable early diagnosis "gold standard". Set up collabration with the expert in National Cheng Kung University Medical Center of Taiwan who did a lot of excellent work in basic research of prevention the progression of acut kidney injury. Study the experience about prevention progression of kidney disease in clinical and basic field. Establish cooperation with the professional in Hong Kong University of Science and Technology. To set up the system of natural products research and assess the Astragalus medicinal value.

Conditions

Acute Kidney Injury

Keywords

acute kidney injury; ultrasound technology

Outcome Measures

Primary Outcomes (1)

• compare the results of kidney ultrasound with biomarkers of acute kidney injury

  up to 24 months

Study Arms (1)

Confirmed acute kidney injury

Confirmed acute kidney injury

Other: kidney ultrasound

Interventions

kidney ultrasound OTHER

kidney ultrasound

Confirmed acute kidney injury

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Confirmed acute kidney injury

You may qualify if:

• Subjects must satisfy the following criteria to be enrolled in the study:
• Clinical diagnosis of acute or chronic kidney injury
• Male or female, aged 18-80 years old
• signed informed consent
• Patients can breathe in, breathe out and hold their breathe with ease, communication without difficulty.

You may not qualify if:

• Potential subjects who meet any of the following criteria will be excluded from participating in the study:
• Refuse to sign informed consent
• allergy to micro bubble hexafluoride drug
• Patients with cardiopulmonary insufficiency, pleural effusion, pulmonary infections
• Patients with asthma, chronic bronchitis
• Patients with pregnancy
• Patients can't cooperate or have a difficulty in breathing in, breathing out or holding their breathe
• Patients beening diagnosed with End-stage kidney disease.

Sponsors & Collaborators

• RenJi Hospital: lead
• China-Japan Friendship Hospital: collaborator
• National Cheng-Kung University Hospital: collaborator

Study Sites (1)

Department of nephrology , Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200127, China

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

only plasma and urine

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases

Study Officials

• shan mou, Dr.

  Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 22, 2015
• First Posted: January 28, 2015
• Study Start: April 1, 2014
• Primary Completion: November 15, 2017
• Study Completion: December 30, 2017
• Last Updated: November 27, 2023

Record last verified: 2023-11

Locations

CN (1)